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http://dx.doi.org/10.1016/j.jfma.201Myoclonic astatic epilepsy (MAE) is characterized by multiple seizure types, which are often
refractory. Although vagus nerve stimulation (VNS) is an alternative treatment for medically
intractable seizures, its exact mechanism of action remains unclear. Herein, we report the
case of a 4-year-old boy with intractable MAE who has been in a seizure-free status for 2 years
and 3 months since 6 months after the implantation of a vagus nerve stimulator (Model 103,
Cyberonics, Inc., Houston, TX). Various test results 6 months after VNS were compared with
those before VNS. Results of an electroencephalograph revealed disappearance of epilepti-
form discharges and an increased betaegamma spectrum rhythm. The brain diffusion-tensor
imaging showed an increased ratio of fraction anisotropy in the right fimbriaefornix, indi-
cating improved diffusion of the white matter tract, and 18F-fluorodeoxyglucose positron emis-
sion tomography revealed globally improved cerebral glucose metabolism. His cognitive andhave no conflicts of interest relevant to this article.
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Neuroimaging and electroencephalography in MAE after VNS 259socialeemotional performances also improved at 2 years after VNS. To the best of our knowl-
edge, this is the first report to describe the effects of VNS on fimbriaefornix and glucose meta-
bolism in MAE.
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Myoclonic astatic epilepsy (MAE), also known as Doose
syndrome, is a generalized epileptic syndrome of young
children characterized by multiple seizure types, pre-
dominantly myoclonic, astatic, and myoclonic astatic sei-
zures, as well as by generalized toniceclonic seizures,
absence, myoclonic absence, and tonic seizures.1 It should
be differentiated from Dravet syndrome (severe myoclonic
epilepsy of infancy), which begins with febrile seizure in
infants, subsequently evolving into myoclonic seizure and
partial epilepsy. Drop attacks predominate in cases of
MAE, which are different from the tonic seizures
frequently reported in the LennoxeGastaut syndrome.2 In
cases of MAE, electroencephalography (EEG) is character-
ized by a biparietal theta background rhythm, irregularly
generalized spike wave, and polyspike-wave discharges.
Before the onset of epilepsy, children are developmentally
normal and organic brain abnormalities are absent. The
victims may become neurologically regressed if the sei-
zures are intractable. However, little is known about the
optimal treatment of MAE and the efficacy of antiepileptic
treatments has not been studied in randomized clinical
trials.3
Vagus nerve stimulation (VNS) is an alternative treat-
ment for patients with medically refractory epilepsy, who
are unsuitable candidates for conventional epilepsy sur-
gery. It remains the only nonexperimental surgical option
available for patients who need surgical management but
are reluctant to undergo an intracranial procedure.4 The
vagus nerve has a mixed composition with 80% afferent fi-
bers, which originate in the jugular and nodose ganglia and
innervate the nucleus of tractus solitarius bilaterally,
sending projections to various regions associated with
seizure activity.5 By stimulating these afferent fibers, VNS
attempts to remotely exert its antiseizure effects on
intracranial structures. However, the mechanism of these
effects remains unclear.
We herein report the case of a 4-year-old boy with
medically intractable MAE who became seizure free after
undergoing VNS treatment. The changes in EEG and neu-
roimages after VNS, including brain magnetic resonance
imaging (MRI) and positron emission tomography (PET), are
described.
Case report
A 4-year-old boy, the first child of unrelated parents, was
uneventfully delivered by elective cesarean section at 38
weeks of gestation. His growth and development were
normal until 2 years of age when myoclonic jerks before
sleep were noted by his parents. His generalized myoclonicjerks became worse with shoulder shrugs and brief loss of
consciousness (for seconds) 3 months later. There were no
obvious precipitating factors. He was treated with valproic
acid initially, but in vain. Multiple antiepileptic drugs had
then been tried without benefits, including nitrazepam,
levetiracetam, clonazepam, topiramate, vigabatrin, lamo-
trigine, and oral steroids. He still had more than 50
myoclonic jerks, followed by atonic drops with brief
absence seizures daily. He was then referred to our hospi-
tal. Initially, intravenous pyridoxal phosphate (30 mg/kg)
was administered with partial response, which reduced the
number of seizures from 70 to 40 per day. A 24-hour video
EEG showed frequent bursts of symmetric generalized
polyspike waves (Fig. 1A). Results of a brain MRI scan
showed no specific finding. An interictal 18F-fluorodeox-
yglucose PET (18F-FDG PET) study was carried out and the
images revealed diffuse hypometabolism at the bilateral
frontal, parietal, and temporal lobes (Fig. 3A). Statistical
parametric mapping (SPM; SPM99, Wellcome Department of
Imaging Neuroscience, Institute of Neurology, University
College London, London, UK) analysis that compared our
patient with 10 healthy young men (age:
mean Z 33.5  6.0; range Z 20e39) as controls6 (Fig. 3B,
with a height threshold of p < 0.001 and extent-size
threshold of >90 voxels) showed statistically significant
hypometabolism in the marked areas.
MAE was suspected. Adrenocorticotropic hormones were
given for 5 days, but discontinued due to increased number
of seizures up to more than 90 per day. The patient was
then followed up at our neurologic clinic under the treat-
ment of pyridoxine, valproic acid, lamotrigine and clonaz-
epam, with 10e40 drop attacks per day. Global regression
in motor, speech, cognition, and behavior was noted after
frequent seizures. He became very hyperactive, wheel-
chair dependent and incommunicable, lacked verbal
output, and required a helmet to avoid head trauma.
He received a vagus nerve stimulator implantation
(Model 103, Cyberonics, Inc., Houston, TX) at 4 years of
age. Three months after VNS, his major seizures with drops
disappeared, although 7e15 absence seizures persisted
daily. He became more communicable and started to have
social smiles 5 months after VNS. No more seizures were
noted and the EEG showed diffuse beta or gamma spectrum
fast activities (Fig. 1B) without epileptiform discharges 6
months after VNS.
Compared with baseline (Fig. 2A), the fractional anisot-
ropy (FA) map from brain diffusion tensor image (DTI) at 10
months after VNS showed increased FA in the right fim-
briaefornix at the level of both cerebral peduncles (Fig. 2B).
Another PETstudy during VNS,whichwas performedat 1 year
and 3 months after vagus nerve stimulator implantation,
revealed global improvement of glucose metabolism in the
cerebrumand cerebellum (Fig. 3C: axial images; Fig. 3D: SPM
Figure 1 Electroencephalography (EEG) of the patient with myoclonic astatic epilepsy before and after vagus nerve stimulation
(VNS). (A) Pre-VNS interictal EEG reveals symmetrical polyspike-wave discharges. (B) Post-VNS EEG at 6 months shows disap-
pearance of epileptiform discharges and increase in diffuse fast activities (high cut set at 35 Hz).
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threshold of >90 voxels). Slight asymmetric uptake was
noted in the thalamus; the maximal standard uptake value
(SUVmax) of the right thalamus is 6.6, while that of the left
thalamus is 6.1. Thepsychosocial evaluation by Bayley-III at 2
years after VNS showed significant improvement of raw
scores from 41 (equivalent to 12 months old) to 63 (equiva-
lent to 24 months old) in cognitive performance and from 81
to 103 in socialeemotional performance; however, therewasno improvement in language performance (raw scores from
47 to 43).
We started to taper his antiepileptic drugs at 1 year
after VNS. Treatment with clonazepam had been dis-
continued, valproic acid tapered to 7 mg/kg per day, and
lamotrigine therapy maintained at 7 mg/kg per day. He
remains in seizure-free status for more than 2 years, walks
and runs independently, plays with peers, and follows or-
ders. He started to be verbally expressive recently.
Figure 2 Brain magnetic resonance imaging before and after vagus nerve stimulation (VNS). (A) Pre-VNS diffusion tensor imaging
shows decreased fraction anisotropy in the right fimbriaefornix (arrows). (B) Diffusion tensor imaging performed 10 months after
VNS shows improvement in the corresponding area. (C) The cartoon drawing demonstrates the location of fimbriaefornix with their
corresponding axial fractional anisotropy (FA) maps (A,B).
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To the best of our knowledge, this is the first report to
describe the effects of VNS on the fornix and cerebral
glucose metabolism in a patient with MAE.
VNS, usually through the left vagus nerve, was able to
increase activity, measured by neuronal fos expression, in
known vagal projection pathways, e.g., the medullary vagal
complex, locus coeruleus, several thalamic and hypotha-
lamic nuclei, amygdala, and the cingulate and retrosplenial
cortex.7 It was demonstrated to evoke potentials in the
cortex, thalamus, hypothalamus, and amygdala of cats and
monkeys.8,9 In vivo DTI, reported to accurately predict
white matter abnormalities of the fimbriaefornix in human
temporal lobe epilepsy, provides significant validation of
the application of DTI as a noninvasive marker of white
matter pathology in seizure patients.10 The baseline cere-
bral DTI of this patient showed decreased anisotropic
diffusion of white matter in the right fimbriaefornix, whichwas improved after the seizures were controlled by VNS.
The fornix is a bidirectional pathway from the hippocam-
pus, through the hypothalamus to the mammillary bodies
and the anterior nuclei of thalamus, which are the target
locations affected by VNS. Therefore, the fornix may be
involved, while seizures are refractory and later improved
after VNS. It is interesting to note that the 18F-FDG uptake
in the right thalamus is also slightly higher than the uptake
in the left thalamus after VNS in this patient.
18F-FDG PET, based on glucose utilization of brain, may
provide information on the level of neuronal function in the
brain. It has been used in presurgical identification of
epileptic foci for pediatric patients with intractable seiz-
ure.11e15 The interpretation of PET images in the clinical
setting is mostly based on visual interpretation. Objective
voxel-based analysis technique, such as SPM, is not widely
used in pediatric epileptic patients, mainly due to lack of an
age-matched control database. It has been demonstrated by
18F-FDG PET that absolute cerebral glucose metabolic values
Figure 3 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) studies before and after vagus nerve stimulation (VNS)
(A) Pre-VNS PET showing extensive FDG hypometabolism at the bilateral frontal, parietal, and temporal cortex; (B) statistical
parametric mapping (SPM) analysis of pre-VNS PET (p < 0.001, voxel size > 90, uncorrected for multiple comparisons) with 10 young
men (range: 20e39 years) as controls showing extensive significant hypometabolism at the bilateral frontal, bilateral temporal,
bilateral parietal, and left cerebellar regions; (C) PET study performed at 1 year and 3 months after VNS shows global improvement
of FDG metabolism. Note that the FDG uptake in the right thalamus is slightly higher than the uptake in the left thalamus; (D) SPM
analysis of post-VNS PET using the same criteria and normal database.
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rose to reach adult values by 2 years of age.16 Recently, SPM
analysis, using a young adult control group, was shown to be
a complementary objective analytic method in identifying
epileptogenic regions in children older than 6 years.6 We
applied a similar method to the PET study performed at 3
years and 7 months of age in our patient. The PET results of
diffuse pattern of multifocal hypometabolism are consistent
with his EEG findings, and therefore surgery was not a rec-
ommended treatment option.
It has been proposed that VNS produces an effective
decrease in seizure frequency mainly by suppressing the ac-
tivity of ipsilateral thalamus. Perfusion studies using
99mTc-ethylcysteinate dimer single photon emission
computed tomography (SPECT) demonstrate significant
decrease of perfusion in the left thalamus at VNS initializa-
tion.17,18 An animal study using 18F-FDG PET demonstrated
decreased glucose metabolism in the left hippocampus
immediately after VNS and decreased left-to-right ratio inthe striatum after 1 week of continuous VNS.19 Consistent
with the findings of previous reports, we found lower 18F-FDG
uptake in the left thalamus during chronic VNS in our patient.
In addition, we also demonstrate a global increase in the
cerebral glucose metabolism, which may be related to the
seizure-free status of this patient.
Electrical stimulation of vagus nerve causes desynch-
ronization of neuronal activity in cats and humans,20 which
is thought as one of the mechanisms of antiepileptic ac-
tion. Desynchronization may play a role in regulation or
generation of seizuresdsuch as the amygdala, the limbic
cortex, and parts of the thalamusdand those that are
anatomically connected with the vagus nerve.21e23 In an-
imal studies, the 30-Hz (high frequency) VNS setting sup-
presses interictal epileptiform discharges.24 In addition,
EEG beta activity (13e35 Hz) is considered as an index of
central alertness.25 Taken together, the increase in beta or
gamma spectrum fast activities (20e50 Hz) by VNS,
claimed to account for improved attentional performance
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improvement in our patient.
In summary, VNS may be an effective treatment for MAE.
We hypothesize that the antiseizure effects of VNS in the
treatment of MAE may be related to the improvement of
cerebral glucose metabolism and white matter diffusion in
the fornix, which connects the hippocampus and the thal-
amus. The latter may mediate cortical desynchronization,
presenting as the increase in the betaegamma spectrum
rhythm, which accounts for the anticonvulsant action and
improvement in cognitive performance.
References
1. Doose H. Myoclonic-astatic epilepsy. Epilepsy Res Suppl 1992;
6:163e8.
2. Scheffer IE, Berkovic SF. Genetics of epilepsy. In: Swaiman FS,
Ashwal S, Ferriero DM, editors. Pediatric neurology: principle
and practice. 4th ed., vol. 1. Philadelphia: Mosby Elsevier;
2006. p. 1012e3.
3. Kilaru S, Bergqvist AG. Current treatment of myoclonic astatic
epilepsy: clinical experience at the Children’s Hospital of
Philadelphia. Epilepsia 2007;48:1703e7.
4. Milby AH, Halpern CH, Baltuch GH. Vagus nerve stimulation in
the treatment of refractory epilepsy. Neurotherapeutics 2009;
6:228e37.
5. Henry TR. Therapeutic mechanisms of vagus nerve stimulation.
Neurology 2002;59:S3e14.
6. Kumar A, Juha´sz C, Asano E, Sood S, Muzik O, Chugani HT.
Objective detection of epileptic foci by 18F-FDG PET in children
undergoing epilepsy surgery. J Nucl Med 2010;51:1901e7.
7. Naritoku DK, Terry WJ, Helfert RH. Regional induction of fos
immunoreactivity in the brain by anticonvulsant stimulation of
the vagus nerve. Epilepsy Res 1995;22:53e62.
8. Juha´sz G, De´ta´ri L, Kukorelli T. Effects of hypnogenic vagal
stimulation on thalamic neuronal activity in cats. Brain Res
Bull 1985;15:437e41.
9. O’Brien JH, Pimpaneau A, Albe-Fessard D. Evoked cortical re-
sponses to vagal, laryngeal and facial afferents in monkeys
under chloralose anaesthesia. Electroencephalogr Clin Neuro-
physiol 1971;31:7e20.
10. Concha L, Livy DJ, Beaulieu C, Wheatley BM, Gross DW. In vivo
diffusion tensor imagingandhistopathologyof thefimbriaefornix
in temporal lobe epilepsy. J Neurosci 2010;30:996e1002.
11. Sood S, Chugani HT. Functional neuroimaging in the preoper-
ative evaluation of children with drug-resistant epilepsy.
Childs Nerv Syst 2006;22:810e20.
12. da Silva EA, Chugani DC, Muzik O, Chugani HT. Identification of
frontal lobe epileptic foci in children using positron emission
tomography. Epilepsia 1997;38:1198e208.13. Gaillard WD, White S, Malow B, Flamini R, Weinstein S, Sato S,
et al. FDG-PET in children and adolescents with partial sei-
zures: role in epilepsy surgery evaluation. Epilepsy Res 1995;
20:77e84.
14. Juha´sz C, Chugani DC, Muzik O, Shah A, Asano E, Mangner TJ,
et al. Alpha-methyl- -tryptophan PET detects epileptogenic
cortex in children with intractable epilepsy. Neurology 2003;
60:960e8.
15. Snead 3rd OC, Chen LS, Mitchell WG, Kongelbeck SR, Raffel C,
Gilles FH, et al. Usefulness of 18F-fluorodeoxyglucose positron
emission tomography in pediatric epilepsy surgery. Pediatr
Neurol 1996;14:98e107.
16. Chugani HT, Phelps ME, Mazziotta JC. Positron emission to-
mography study of human brain functional development. Ann
Neurol 1987;22:487e97.
17. Van Laere K, Vonck K, Boon P, Brans B, Vandekerckhove T,
Dierckx R, et al. Vagus nerve stimulation in refractory epilepsy:
SPECT activation study. J Nucl Med 2000;41:1145e54.
18. Van Laere K, Vonck K, Boon P, Versijpt J, Dierckx R. Perfusion
SPECT changes after acute and chronic vagus nerve stimulation
in relation to prestimulus condition and long-term clinical ef-
ficacy. J Nucl Med 2002;43:733e44.
19. Dedeurwaerdere S, Cornelissen B, Van Laere K, Vonck K,
Achten E, Slegers G, et al. Small animal positron emission to-
mography during vagus nerve stimulation in rats: a pilot study.
Epilepsy Res 2005;67:133e41.
20. Nemeroff CB, Mayberg HS, Krahl SE, McNamara J, Frazer A,
Henry TR, et al. VNS therapy in treatment-resistant depres-
sion: clinical evidence and putative neurobiological mecha-
nisms. Neuropsychopharmacology 2006;31:1345e55.
21. Hopkins DA, Holstege G. Amygdaloid projections to the
mesencephalon, pons and medulla oblongata in the cat. Exp
Brain Res 1978;32:529e47.
22. Ito S, Craig AD. Vagal-evoked activity in the parafascicular
nucleus of the primate thalamus. J Neurophysiol 2005;94:
2976e82.
23. Ricardo JA, Koh ET. Anatomical evidence of direct projections
from the nucleus of the solitary tract to the hypothalamus,
amygdala, and other forebrain structures in the rat. Brain Res
1978;153:1e26.
24. Crystal GJ, Zhou X, Alam S, Piotrowski A, Hu G. Lack of role for
nitric oxide in cholinergic modulation of myocardial contrac-
tility in vivo. Am J Physiol Heart Circ Physiol 2001;281:
H198e206.
25. Chapotot F, Gronfier C, Jouny C, Muzet A, Brandenberger G.
Cortisol secretion is related to electroencephalographic
alertness in human subjects during daytime wakefulness. J Clin
Endocrinol Metab 1998;83:4263e8.
26. Marrosu F, Santoni F, Puligheddu M, Barberini L, Maleci A,
Ennas F, et al. Increase in 20e50 Hz (gamma frequencies)
power spectrum and synchronization after chronic vagal nerve
stimulation. Clin Neurophysiol 2005;116:2026e36.
